期刊
DRUG DISCOVERY TODAY
卷 26, 期 2, 页码 490-502出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.10.028
关键词
-
资金
- Science & Technology Fund of Hebei Agricultural University [LG201805]
USP7, as a deubiquitinating enzyme, plays a crucial role in cancer and other diseases, with current research focusing on its role in tumorigenesis, clinical studies, and development of inhibitors. A comprehensive understanding of USP7 could provide insights for drug discovery in various diseases.
Human ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme that removes the ubiquitin (Ub) protein and spares substrates from degradation. Given its regulation of proteins involved in several cellular processes, abnormal expression and activity of USP7 are associated with several types of disease, including cancer. In this review, we summarize the developments in our understanding of USP7 over the past 5 years, focusing on its role in related cancers. Furthermore, we discuss clinical studies of USP7, including in vivo and pharmacological studies, as well as the development of USP7 inhibitors. A comprehensive understanding of USP7 will expand our knowledge of the structure and function of USP7-mediated signaling and shed light on drug discovery for different diseases in which USP7 is implicated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据